Detalhe da pesquisa
1.
Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses.
Nat Immunol
; 23(3): 380-385, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35115679
2.
Heart of the matter-infection and xenotransplantation.
Transpl Infect Dis
; 26(1): e14206, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38055610
3.
Interesting case from Argentina: Kidney transplant recipient with skin lesions-A Latin American perspective.
Transpl Infect Dis
; 26(2): e14243, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38407514
4.
COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future.
J Infect Dis
; 228(Suppl 1): S55-S69, 2023 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37539765
5.
Omicron BA.4/5 Neutralization and T-Cell Responses in Organ Transplant Recipients After Booster Messenger RNA Vaccine: A Multicenter Cohort Study.
Clin Infect Dis
; 77(2): 229-236, 2023 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36975097
6.
Vaccine schedule recommendations and updates for patients with hematologic malignancy post-hematopoietic cell transplant or CAR T-cell therapy.
Transpl Infect Dis
; 25 Suppl 1: e14109, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515788
7.
Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial.
Ann Intern Med
; 175(2): 226-233, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34807716
8.
Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccine.
Am J Transplant
; 22(8): 2089-2093, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35266606
9.
Utility of Cytomegalovirus Cell-Mediated Immunity Assays in Solid Organ Transplantation.
J Clin Microbiol
; 60(8): e0171621, 2022 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35543099
10.
Severity of COVID-19 among solid organ transplant recipients in Canada, 2020-2021: a prospective, multicentre cohort study.
CMAJ
; 194(33): E1155-E1163, 2022 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302101
11.
Severe Acute Respiratory Syndrome Coronavirus 2 Infection Induces Greater T-Cell Responses Compared to Vaccination in Solid Organ Transplant Recipients.
J Infect Dis
; 224(11): 1849-1860, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739078
12.
Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients.
Am J Transplant
; 21(12): 3980-3989, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34347934
13.
Impact of immunosuppression on the immune response to SARS-CoV-2 infection: A mechanistic study.
Transpl Infect Dis
; 23(6): e13743, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34668283
14.
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
N Engl J Med
; 385(13): 1244-1246, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379917
15.
Learning how to treat coronavirus disease 2019 in hematopoietic stem cell transplant patients.
Transpl Infect Dis
; 25(1): e14005, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36639954
16.
Parvovirus B19 in stem cell transplantation.
Transpl Infect Dis
; 25(5): e14138, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37610327
17.
COVID-19 Reinfection Has Better Outcomes Than the First Infection in Solid Organ Transplant Recipients.
Transplantation
; 108(5): 1249-1256, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291585
18.
Breakthrough Invasive Fungal Infection After Coadministration of Venetoclax and Voriconazole.
Open Forum Infect Dis
; 10(3): ofad134, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37008567
19.
High Rates of Seroprotection and Seroconversion to Vaccine-Preventable Infections in the Early Post-Autologous Stem Cell Transplant Period.
Open Forum Infect Dis
; 10(10): ofad497, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37869409
20.
Evolution of Humoral and Cellular Immunity Post-Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab.
Open Forum Infect Dis
; 10(11): ofad550, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38023562